{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:39:49Z","timestamp":1785937189827,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T00:00:00Z","timestamp":1171843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T00:00:00Z","timestamp":1171843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1038\/sj.bmt.1705614","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T16:13:02Z","timestamp":1171901582000},"page":"425-429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":202,"title":["Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy"],"prefix":"10.1038","volume":"39","author":[{"given":"S M","family":"Trifilio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C L","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P R","family":"Yarnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"McKoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Parada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Chamilos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Palella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Mullane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Tallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Evens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M H","family":"Scheetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D P","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,19]]},"reference":[{"key":"BF1705614_CR1","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","volume":"41","author":"MM Roden","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634\u2013653.","journal-title":"Clin Infect Dis"},{"key":"BF1705614_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1086\/430710","volume":"41","author":"G Chamilos","year":"2005","unstructured":"Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP . Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 2005; 41: 60\u201366.","journal-title":"Clin Infect Dis"},{"key":"BF1705614_CR3","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1056\/NEJM200402263500923","volume":"350","author":"FM Marty","year":"2004","unstructured":"Marty FM, Cosimi LA, Baden LR . Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004; 350: 950\u2013952.","journal-title":"N Engl J Med"},{"key":"BF1705614_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1086\/423274","volume":"39","author":"A Imhof","year":"2004","unstructured":"Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA . Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004; 39: 743\u2013746.","journal-title":"Clin Infect Dis"},{"key":"BF1705614_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1086\/422723","volume":"39","author":"GT Siwek","year":"2004","unstructured":"Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39: 584\u2013587.","journal-title":"Clin Infect Dis"},{"key":"BF1705614_CR6","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1086\/428780","volume":"191","author":"DP Kontoyiannis","year":"2005","unstructured":"Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C et al. Zygomycosis in a tertiary care cancer center in the era of Aspergillus-active antifungal therapy: a case control observational study of 27 recent cases. J Infect Dis 2005; 191: 1350\u20131360.","journal-title":"J Infect Dis"},{"key":"BF1705614_CR7","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1128\/AAC.46.5.1581-1582.2002","volume":"46","author":"QN Sun","year":"2002","unstructured":"Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR . In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother 2002; 46: 1581\u20131582.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1705614_CR8","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1001\/jama.293.17.2131","volume":"293","author":"CL Bennett","year":"2005","unstructured":"Bennett CL, Nebeker JR, Lyons EA, Samore MH, Feldman MD, McKoy JM et al. The Research on Adverse Drug Events and Report (RADAR) project. JAMA 2005; 293: 2131\u20132140.","journal-title":"JAMA"},{"key":"BF1705614_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F et al. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7\u201314.","journal-title":"Clin Infect Dis"},{"key":"BF1705614_CR10","volume-title":"Optimal Data Analysis: Guidebook with Software for Windows","author":"PR Yarnold","year":"2005","unstructured":"Yarnold PR, Soltysik RC . Optimal Data Analysis: Guidebook with Software for Windows. APA Books: Washington, DC, 2005."},{"key":"BF1705614_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","volume":"18","author":"B Spellberg","year":"2005","unstructured":"Spellberg B, Edwards Jr J, Ibrahim A . Novel perspectives on Mucormycosis: pathophysiology, presentation and management. Clin Microbiol Rev 2005; 18: 556\u2013569.","journal-title":"Clin Microbiol Rev"},{"key":"BF1705614_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1128\/AAC.49.2.830-832.2005","volume":"49","author":"B Spellberg","year":"2005","unstructured":"Spellberg B, Fu Y, Edwards Jr JE, Ibrahim AS . Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice. Antimicrob Agents Chemother 2005; 49: 830\u2013832.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1705614_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","volume":"50","author":"RN Greenberg","year":"2006","unstructured":"Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006; 50: 126\u2013133.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1705614_CR14","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1086\/500212","volume":"42","author":"JA van Burik","year":"2006","unstructured":"van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP . Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006; 42: e61\u2013e65 (E-pub 2006 Feb 21; erratum in Clin infect Dis 2006; 43: 1376).","journal-title":"Clin Infect Dis"},{"key":"BF1705614_CR15","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1128\/AAC.00163-06","volume":"50","author":"F Sabatelli","year":"2006","unstructured":"Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R et al. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 2006; 50: 2009\u20132015.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"BF1705614_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1439-0507.2002.tb04542.x","volume":"45","author":"V Rickerts","year":"2002","unstructured":"Rickerts V, Bohme A, Just-Nubling G . Risk factor for invasive zygomycosis in patients with hematologic malignancies. Mycoses 2002; 45 (Suppl 1): 27\u201330.","journal-title":"Mycoses"},{"key":"BF1705614_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/315193","volume":"181","author":"KA Marr","year":"2000","unstructured":"Marr KA, Seidel K, White TC, Bowden RA . Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000; 181: 309\u2013316.","journal-title":"J Infect Dis"},{"key":"BF1705614_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/sj.bmt.1704828","volume":"35","author":"S Trifilio","year":"2005","unstructured":"Trifilio S, Ortiz R, Pennick G, Verma A, Pi J, Stosor V et al. Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2005; 35: 509\u2013513.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705614_CR19","doi-asserted-by":"crossref","unstructured":"Trifilio S, Singhal S, Williams S, Winter J, Tallman M, Gordon L et al. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Blood (ASH Annual Meeting Abstracts) 2006, Abstract number 2849.","DOI":"10.1182\/blood.V108.11.2849.2849"},{"key":"BF1705614_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.diagmicrobio.2006.01.018","volume":"55","author":"GT Siwek","year":"2006","unstructured":"Siwek GT, Pfaller MA, Polgreen PM, Cobb S, Hoth P, Magalheas-Silverman M et al. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis. Diagn Microbiol Infect Dis 2006; 55: 209\u2013212.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"BF1705614_CR21","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJMoa040446","volume":"351","author":"TJ Walsh","year":"2004","unstructured":"Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351: 1391\u20131402.","journal-title":"N Engl J Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705614.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705614","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705614.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:29:30Z","timestamp":1648081770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,19]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["BF1705614"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705614","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,19]]},"assertion":[{"value":"21 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}